 Lyle Burdine
Concepts (202)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Transplantation | 5 | 2024 | 203 | 1.770 |
Why?
| | DNA-Activated Protein Kinase | 6 | 2026 | 24 | 1.430 |
Why?
| | Liver Transplantation | 8 | 2025 | 174 | 1.250 |
Why?
| | Tissue and Organ Procurement | 3 | 2024 | 52 | 1.170 |
Why?
| | Tissue Donors | 5 | 2024 | 130 | 1.060 |
Why?
| | Bile Ducts | 2 | 2025 | 48 | 0.900 |
Why?
| | Graft Survival | 7 | 2022 | 157 | 0.880 |
Why?
| | Cholecystectomy | 1 | 2021 | 30 | 0.680 |
Why?
| | Postoperative Care | 1 | 2021 | 109 | 0.650 |
Why?
| | Organ Transplantation | 1 | 2020 | 48 | 0.630 |
Why?
| | Nuclear Proteins | 2 | 2026 | 250 | 0.610 |
Why?
| | Patient Readmission | 1 | 2021 | 251 | 0.580 |
Why?
| | Interleukin-2 | 1 | 2017 | 69 | 0.530 |
Why?
| | Calcineurin | 1 | 2017 | 76 | 0.490 |
Why?
| | Carcinoma, Neuroendocrine | 1 | 2015 | 27 | 0.450 |
Why?
| | Proto-Oncogene Proteins c-ret | 1 | 2015 | 33 | 0.440 |
Why?
| | Hepatic Artery | 2 | 2025 | 21 | 0.440 |
Why?
| | Thyroid Neoplasms | 1 | 2015 | 113 | 0.410 |
Why?
| | Cold Ischemia | 3 | 2025 | 11 | 0.400 |
Why?
| | Chromones | 2 | 2024 | 16 | 0.390 |
Why?
| | Morpholines | 2 | 2024 | 64 | 0.380 |
Why?
| | Proteomics | 1 | 2015 | 336 | 0.380 |
Why?
| | DNA-Binding Proteins | 5 | 2026 | 423 | 0.360 |
Why?
| | Delayed Graft Function | 2 | 2022 | 11 | 0.330 |
Why?
| | Graft Rejection | 2 | 2022 | 166 | 0.330 |
Why?
| | Peptides | 4 | 2009 | 234 | 0.330 |
Why?
| | Humans | 27 | 2026 | 53230 | 0.320 |
Why?
| | Dihydroxyphenylalanine | 3 | 2006 | 5 | 0.300 |
Why?
| | Periodic Acid | 2 | 2006 | 3 | 0.280 |
Why?
| | Cross-Linking Reagents | 5 | 2008 | 43 | 0.280 |
Why?
| | Middle Aged | 9 | 2025 | 13419 | 0.280 |
Why?
| | Phosphorylation | 3 | 2026 | 533 | 0.270 |
Why?
| | Saccharomyces cerevisiae Proteins | 3 | 2008 | 131 | 0.270 |
Why?
| | United States | 5 | 2024 | 5409 | 0.240 |
Why?
| | Treatment Outcome | 7 | 2025 | 5595 | 0.230 |
Why?
| | Time Factors | 4 | 2025 | 2991 | 0.230 |
Why?
| | T-Lymphocytes, Cytotoxic | 1 | 2026 | 67 | 0.230 |
Why?
| | Lymphocyte Activation | 2 | 2026 | 163 | 0.230 |
Why?
| | Organ Preservation | 1 | 2025 | 33 | 0.220 |
Why?
| | Risk Assessment | 3 | 2025 | 1368 | 0.220 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2026 | 202 | 0.220 |
Why?
| | Donor Selection | 1 | 2024 | 21 | 0.220 |
Why?
| | Retrospective Studies | 8 | 2025 | 6819 | 0.220 |
Why?
| | Receptors, Drug | 1 | 2004 | 4 | 0.210 |
Why?
| | Ischemia | 1 | 2025 | 158 | 0.210 |
Why?
| | Signal Transduction | 2 | 2026 | 1748 | 0.210 |
Why?
| | Female | 11 | 2025 | 28782 | 0.210 |
Why?
| | Solubility | 1 | 2024 | 83 | 0.210 |
Why?
| | Risk Factors | 5 | 2025 | 4017 | 0.210 |
Why?
| | Thrombectomy | 1 | 2024 | 74 | 0.200 |
Why?
| | Transplants | 1 | 2023 | 19 | 0.200 |
Why?
| | Repressor Proteins | 1 | 2004 | 149 | 0.200 |
Why?
| | Membrane Proteins | 1 | 2026 | 333 | 0.200 |
Why?
| | Male | 9 | 2025 | 27435 | 0.200 |
Why?
| | Transcriptional Activation | 2 | 2017 | 128 | 0.200 |
Why?
| | T-Lymphocytes | 2 | 2024 | 321 | 0.200 |
Why?
| | Antibody Formation | 1 | 2022 | 49 | 0.190 |
Why?
| | Protein Kinase Inhibitors | 1 | 2024 | 233 | 0.190 |
Why?
| | Creatinine | 1 | 2022 | 158 | 0.180 |
Why?
| | Hospitals, Low-Volume | 1 | 2021 | 17 | 0.180 |
Why?
| | Cholecystostomy | 1 | 2021 | 8 | 0.180 |
Why?
| | Cholecystitis | 1 | 2021 | 12 | 0.180 |
Why?
| | Hospitals, High-Volume | 1 | 2021 | 26 | 0.180 |
Why?
| | Jurkat Cells | 2 | 2021 | 29 | 0.180 |
Why?
| | Cholecystitis, Acute | 1 | 2021 | 14 | 0.180 |
Why?
| | Early Growth Response Protein 1 | 1 | 2021 | 34 | 0.180 |
Why?
| | Protein Stability | 2 | 2021 | 45 | 0.180 |
Why?
| | Databases as Topic | 1 | 2021 | 38 | 0.170 |
Why?
| | Cholecystectomy, Laparoscopic | 1 | 2021 | 23 | 0.170 |
Why?
| | Stents | 1 | 2024 | 376 | 0.170 |
Why?
| | Skin Transplantation | 1 | 2021 | 43 | 0.170 |
Why?
| | Graft vs Host Disease | 1 | 2020 | 93 | 0.150 |
Why?
| | Immunocompromised Host | 1 | 2020 | 124 | 0.150 |
Why?
| | Wounds and Injuries | 1 | 2022 | 301 | 0.150 |
Why?
| | Warm Ischemia | 1 | 2018 | 3 | 0.150 |
Why?
| | Reoperation | 1 | 2021 | 476 | 0.150 |
Why?
| | Tissue and Organ Harvesting | 1 | 2018 | 25 | 0.140 |
Why?
| | Hepatectomy | 1 | 2018 | 26 | 0.140 |
Why?
| | Operative Time | 1 | 2018 | 78 | 0.140 |
Why?
| | Central Venous Pressure | 1 | 2018 | 6 | 0.140 |
Why?
| | Living Donors | 1 | 2018 | 27 | 0.140 |
Why?
| | Intraoperative Care | 1 | 2018 | 51 | 0.140 |
Why?
| | NFATC Transcription Factors | 1 | 2017 | 26 | 0.130 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2017 | 35 | 0.130 |
Why?
| | Renal Insufficiency | 1 | 2018 | 108 | 0.130 |
Why?
| | Monitoring, Physiologic | 1 | 2018 | 122 | 0.130 |
Why?
| | Adult | 5 | 2025 | 14534 | 0.130 |
Why?
| | End Stage Liver Disease | 1 | 2018 | 52 | 0.130 |
Why?
| | Oligopeptides | 1 | 2017 | 94 | 0.130 |
Why?
| | Cell Line, Tumor | 2 | 2024 | 1470 | 0.120 |
Why?
| | Renal Dialysis | 1 | 2018 | 196 | 0.120 |
Why?
| | Protein Processing, Post-Translational | 1 | 2017 | 149 | 0.120 |
Why?
| | Aged | 4 | 2025 | 10429 | 0.120 |
Why?
| | Kidney Failure, Chronic | 1 | 2018 | 210 | 0.120 |
Why?
| | Neoplasms | 1 | 2026 | 1334 | 0.120 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2020 | 610 | 0.110 |
Why?
| | Gene Expression | 1 | 2017 | 618 | 0.110 |
Why?
| | Antineoplastic Agents | 1 | 2023 | 1232 | 0.110 |
Why?
| | CD8-Positive T-Lymphocytes | 2 | 2026 | 145 | 0.100 |
Why?
| | Liver | 3 | 2025 | 1150 | 0.100 |
Why?
| | DNA | 3 | 2023 | 535 | 0.100 |
Why?
| | Mice | 4 | 2026 | 5982 | 0.090 |
Why?
| | Indoles | 1 | 2015 | 280 | 0.090 |
Why?
| | Death | 2 | 2022 | 23 | 0.090 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2015 | 868 | 0.090 |
Why?
| | Mice, Inbred BALB C | 2 | 2021 | 310 | 0.080 |
Why?
| | Amino Acid Sequence | 3 | 2005 | 563 | 0.080 |
Why?
| | Cholera Toxin | 1 | 2009 | 15 | 0.080 |
Why?
| | Molecular Sequence Data | 3 | 2005 | 759 | 0.080 |
Why?
| | Animals | 5 | 2026 | 13526 | 0.070 |
Why?
| | Quinones | 2 | 2006 | 9 | 0.070 |
Why?
| | Proteasome Endopeptidase Complex | 2 | 2008 | 141 | 0.070 |
Why?
| | Mice, Inbred C57BL | 2 | 2026 | 1925 | 0.070 |
Why?
| | Ubiquitin | 1 | 2008 | 70 | 0.070 |
Why?
| | Intestinal Mucosa | 1 | 2009 | 229 | 0.070 |
Why?
| | Peptide Nucleic Acids | 1 | 2006 | 18 | 0.060 |
Why?
| | Follow-Up Studies | 2 | 2025 | 2318 | 0.060 |
Why?
| | Immunological Synapses | 1 | 2026 | 3 | 0.060 |
Why?
| | Wiskott-Aldrich Syndrome Protein, Neuronal | 1 | 2005 | 1 | 0.060 |
Why?
| | Actin-Related Protein 2-3 Complex | 1 | 2005 | 3 | 0.060 |
Why?
| | Bacterial Proteins | 1 | 2009 | 347 | 0.060 |
Why?
| | Choledochostomy | 1 | 2025 | 4 | 0.060 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2026 | 52 | 0.060 |
Why?
| | Transplantation, Homologous | 1 | 2026 | 154 | 0.060 |
Why?
| | Perfusion | 1 | 2025 | 49 | 0.060 |
Why?
| | Proteins | 1 | 2007 | 351 | 0.050 |
Why?
| | Combinatorial Chemistry Techniques | 1 | 2004 | 9 | 0.050 |
Why?
| | Genetic Techniques | 1 | 2004 | 15 | 0.050 |
Why?
| | Suction | 1 | 2024 | 22 | 0.050 |
Why?
| | Chromatography, Affinity | 1 | 2004 | 36 | 0.050 |
Why?
| | Vascular Patency | 1 | 2024 | 88 | 0.050 |
Why?
| | Biosensing Techniques | 1 | 2004 | 32 | 0.050 |
Why?
| | Radiography, Interventional | 1 | 2024 | 58 | 0.050 |
Why?
| | Vascular Surgical Procedures | 1 | 2025 | 171 | 0.050 |
Why?
| | Oxidation-Reduction | 1 | 2004 | 333 | 0.050 |
Why?
| | Social Class | 1 | 2023 | 97 | 0.050 |
Why?
| | DNA Damage | 1 | 2024 | 309 | 0.050 |
Why?
| | Protein Binding | 3 | 2009 | 670 | 0.050 |
Why?
| | Resuscitation | 1 | 2022 | 72 | 0.050 |
Why?
| | Transcription Factors | 1 | 2005 | 571 | 0.050 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2023 | 166 | 0.040 |
Why?
| | Waiting Lists | 1 | 2021 | 56 | 0.040 |
Why?
| | Blood Transfusion | 1 | 2022 | 127 | 0.040 |
Why?
| | Mice, Inbred NOD | 1 | 2021 | 90 | 0.040 |
Why?
| | Thrombosis | 1 | 2024 | 250 | 0.040 |
Why?
| | Endovascular Procedures | 1 | 2024 | 193 | 0.040 |
Why?
| | Mice, SCID | 1 | 2021 | 180 | 0.040 |
Why?
| | Socioeconomic Factors | 1 | 2023 | 623 | 0.040 |
Why?
| | Polymerase Chain Reaction | 1 | 2022 | 452 | 0.040 |
Why?
| | Trauma Centers | 1 | 2022 | 210 | 0.040 |
Why?
| | Mutation, Missense | 1 | 2021 | 110 | 0.040 |
Why?
| | Brain Death | 1 | 2021 | 21 | 0.040 |
Why?
| | Hemorrhage | 1 | 2022 | 226 | 0.040 |
Why?
| | Time-to-Treatment | 1 | 2021 | 81 | 0.040 |
Why?
| | Nitriles | 1 | 2020 | 55 | 0.040 |
Why?
| | Transcription, Genetic | 1 | 2021 | 374 | 0.040 |
Why?
| | Healthcare Disparities | 1 | 2023 | 312 | 0.040 |
Why?
| | Flow Cytometry | 1 | 2021 | 400 | 0.040 |
Why?
| | Pyrazoles | 1 | 2020 | 123 | 0.040 |
Why?
| | Incidence | 1 | 2022 | 1085 | 0.040 |
Why?
| | Pyrimidines | 1 | 2020 | 205 | 0.040 |
Why?
| | Primary Graft Dysfunction | 1 | 2018 | 3 | 0.040 |
Why?
| | Liver Function Tests | 1 | 2018 | 47 | 0.040 |
Why?
| | Cytokines | 1 | 2021 | 627 | 0.040 |
Why?
| | Hyperkalemia | 1 | 2018 | 12 | 0.040 |
Why?
| | Registries | 1 | 2021 | 652 | 0.030 |
Why?
| | Decision Support Techniques | 1 | 2018 | 73 | 0.030 |
Why?
| | Kidney Function Tests | 1 | 2018 | 55 | 0.030 |
Why?
| | Acidosis | 1 | 2018 | 37 | 0.030 |
Why?
| | Length of Stay | 1 | 2021 | 684 | 0.030 |
Why?
| | Perioperative Care | 1 | 2018 | 44 | 0.030 |
Why?
| | Glomerular Filtration Rate | 1 | 2018 | 128 | 0.030 |
Why?
| | Propensity Score | 1 | 2018 | 170 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2018 | 934 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2021 | 1517 | 0.030 |
Why?
| | Cohort Studies | 1 | 2018 | 1557 | 0.030 |
Why?
| | Kidney | 1 | 2018 | 715 | 0.020 |
Why?
| | Prognosis | 1 | 2018 | 2118 | 0.020 |
Why?
| | Peptide Library | 1 | 2009 | 16 | 0.020 |
Why?
| | Protein Subunits | 1 | 2009 | 77 | 0.020 |
Why?
| | Ligands | 1 | 2009 | 203 | 0.020 |
Why?
| | Bacterial Infections | 1 | 2009 | 96 | 0.020 |
Why?
| | Inhibitory Concentration 50 | 1 | 2008 | 75 | 0.020 |
Why?
| | Hydrolysis | 1 | 2008 | 67 | 0.020 |
Why?
| | Models, Chemical | 1 | 2008 | 65 | 0.020 |
Why?
| | Escherichia coli | 1 | 2009 | 183 | 0.020 |
Why?
| | Adenosine Triphosphatases | 1 | 2008 | 92 | 0.020 |
Why?
| | HeLa Cells | 1 | 2008 | 243 | 0.020 |
Why?
| | Saccharomyces cerevisiae | 1 | 2008 | 166 | 0.020 |
Why?
| | Molecular Structure | 1 | 2007 | 320 | 0.020 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2006 | 68 | 0.020 |
Why?
| | Cell Line | 1 | 2009 | 1016 | 0.020 |
Why?
| | Actin-Related Protein 3 | 1 | 2005 | 1 | 0.010 |
Why?
| | Photochemistry | 1 | 2005 | 8 | 0.010 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 1 | 2005 | 33 | 0.010 |
Why?
| | Amino Acid Motifs | 1 | 2005 | 59 | 0.010 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2006 | 333 | 0.010 |
Why?
| | Cattle | 1 | 2005 | 207 | 0.010 |
Why?
| | Binding Sites | 1 | 2005 | 373 | 0.010 |
Why?
| | Models, Molecular | 1 | 2005 | 352 | 0.010 |
Why?
| | Amino Acids | 1 | 2006 | 382 | 0.010 |
Why?
| | Mutation | 1 | 2007 | 1337 | 0.010 |
Why?
|
|
Burdine's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|